Cargando…

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland

BACKGROUND AND AIMS: People who inject drugs (PWID) experience high incarceration rates, and previous incarceration is associated with elevated hepatitis C virus (HCV) transmission risk. In Scotland, national survey data indicate lower HCV incidence in prison than the community (4.3 versus 7.3 per 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stone, Jack, Martin, Natasha K., Hickman, Matthew, Hutchinson, Sharon J., Aspinall, Esther, Taylor, Avril, Munro, Alison, Dunleavy, Karen, Peters, Erica, Bramley, Peter, Hayes, Peter C., Goldberg, David J., Vickerman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	HCV Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461206/ https://www.ncbi.nlm.nih.gov/pubmed/28257600 http://dx.doi.org/10.1111/add.13783

Ejemplares similares

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens
por: Shah, Rajiv, et al.
Publicado: (2021)

Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
por: Stone, Jack, et al.
Publicado: (2020)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
por: Stone, Jack, et al.
Publicado: (2022)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
por: Ward, Zoe, et al.
Publicado: (2019)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
por: Harris, R. J., et al.
Publicado: (2016)

Prisoners should not be left behind in HCV research and policies
por: Moazen, Babak, et al.
Publicado: (2020)

A retrospective study to find the prevalence of HIV, HCV and dual HIV-HCV infection in the prison inmates
por: Singh, Gur Parkash, et al.
Publicado: (2022)

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
por: Martin, Natasha K., et al.
Publicado: (2016)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

The cost‐effectiveness of testing for NS5a resistance‐associated polymorphisms at baseline in genotype 1a‐infected (treatment‐naïve and treatment‐experienced) subjects treated with all‐oral elbasvir/grazoprevir regimens in the United States
por: Elbasha, E. H., et al.
Publicado: (2016)

HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects
por: Fiore, Vito, et al.
Publicado: (2022)

Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil
por: Puga, Marco Antonio Moreira, et al.
Publicado: (2017)

Telemedicine and specialised consultations in prisons. The example of HCV chronic hepatitis
por: Fernández Rodríguez, C, et al.
Publicado: (2019)

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review
por: Gillies, Michelle, et al.
Publicado: (2010)

HIV/STI/HCV Risk Clusters and Hierarchies Experienced by Women Recently Released from Incarceration
por: Johnson, Karen A., et al.
Publicado: (2023)

Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions
por: Palmateer, Norah E., et al.
Publicado: (2014)

HIV and incarceration: prisons and detention
por: Jürgens, Ralf, et al.
Publicado: (2011)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

HCV infected prisoners: should they be still considered a difficult to treat population?
por: Iacomi, Fabio, et al.
Publicado: (2013)

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
por: Brandolini, Micaela, et al.
Publicado: (2013)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

The Death-Rate and the Diseases of Prisoners in the Prisons of Scotland
por: Thomson, J. Bruce
Publicado: (1870)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz
por: Tyczyno, Malgorzata, et al.
Publicado: (2014)

Barriers and facilitators to hepatitis C (HCV) screening and treatment—a description of prisoners’ perspective
por: Crowley, Des, et al.
Publicado: (2018)

Cost-Effectiveness of HBV and HCV Screening Strategies – A Systematic Review of Existing Modelling Techniques
por: Geue, Claudia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9ulqspol4bmaubma4uiqqbstni